DrugPatentWatch Database Preview
Degarelix acetate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for degarelix acetate and what is the scope of patent protection?
Degarelix acetate
is the generic ingredient in one branded drug marketed by Ferring and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Degarelix acetate has one hundred and forty patent family members in thirty-six countries.
One supplier is listed for this compound.
Summary for degarelix acetate
| International Patents: | 140 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 37 |
| Clinical Trials: | 29 |
| Patent Applications: | 1,732 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for degarelix acetate |
| DailyMed Link: | degarelix acetate at DailyMed |
Recent Clinical Trials for degarelix acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NRG Oncology | Phase 3 |
| Alliance for Clinical Trials in Oncology | Phase 3 |
| Bristol-Myers Squibb | Early Phase 1 |
Paragraph IV (Patent) Challenges for DEGARELIX ACETATE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| FIRMAGON | POWDER;SUBCUTANEOUS | degarelix acetate | 022201 | 2019-12-20 |
US Patents and Regulatory Information for degarelix acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for degarelix acetate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2019218360 | Start Trial |
| Hong Kong | 1176552 | Start Trial |
| Mexico | 2010008816 | Start Trial |
| Slovenia | 1003774 | Start Trial |
| Netherlands | 300395 | Start Trial |
| Denmark | 2650012 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for degarelix acetate
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1003774 | PA2009005 | Lithuania | Start Trial | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
| 1003774 | CA 2009 00022 | Denmark | Start Trial | |
| 1003774 | PA2009005,C1003774 | Lithuania | Start Trial | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
| 1003774 | 300395 | Netherlands | Start Trial | 300395, 20180413, EXPIRES: 20230412 |
| 1003774 | C01003774/01 | Switzerland | Start Trial | PRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010 |
| 1003774 | 122009000033 | Germany | Start Trial | PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
